Company research / AXIM
Axim Biotechnologies, Inc. (AXIM)
- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
For the year ended 2023-12-31, Axim Biotechnologies, Inc. reported revenue of $39.5K. Revenue grew 345.3% from the prior annual period.
Key ratios (year ended 2023-12-31)
n/m
Operating margin
n/m
Net margin
345.3%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.